Table Of Content

Steroids Steroids 66 (2001) 911-913 Author Index of Volume 66 Abadji, V., 785 Creatsas, G., 695 Abrescia, P., 889 Guggino, S.E., 347 Cross, H.S., 287 Adamski, J., 49 Gutierrez, S., 159 Csanddi, J.J., 645 Akimoto, K., 701 Cui, JG., 33 Allan, G.F., 663 Allen Tucker, H., 71 Haberey, M., 257 Andrié, S., 645 Habrioux, G., 749 Daifu, Y., 865 Andris, F., 39 Hagey, L.R., 875 Dale, B., 889 Arcson, O.N., 645 Haroutounian, S.A., 785 De Battisti, A., 63 Astecker, N., 399, 45] Hartmann, M., 759 de Groot, A., 569 Hase, T.A., 777 Dean, D.D., 363. 683 Hashimoto, T., 107 DeLuca, H.F., 277 Bajna, E., 287 Hassan, H.A., 71 Demoly, P., 597 Balaguer, P., 597 Hatakeyama DeVeau, P., 683 Balestrieri, M., 889 Heidrich, D.D., 763 Djurendié, E.A., 645 Bareis, P., 287 Henriquet, C., 597 Do, S., 239 Baudino, T.A., 17] Henry, H.L., 147, 39] Dorr, H.G., 737. 817 Baus, E., 39 Herdick, M., 213 Détsch, J., 817 Beneytout, J.-L., 749 Herzig, G., 399, 409, 45] Bertin, P., 749 Dowd, D.R.. 171 Higashi, T., 865 Drachenova, O.A.. 569 Bhatia, B., 511 Higashiyama, T., 87 Duchier, C 3 Bicikova, M., 55 Hiipakka, R.A., 473 Dwivedi, P.P., 381 Bikle, D.D., 339, 409 Hill, M., 55 Binderup, E., 539 Hofer, H., 287 Bischof, M.G., 287 Homoki, J., 759 Egger, H., 409, 451 Bishop, J.E., 147 Hu, F.-x., 905 Eguchi, H., 227 Bjérkling, F., 539 Hu, H., 655 Enright, W.J., 71 Blehr, L.K.A., 539 Hu, J., 655 Evangelopoulos, D., 695 Bobrovnikova, E.A.. 381 Eyes, S:¥.,.3 Hu, Y., 6 Bonner, E., 287 Hutchins, A., 663 Boudi, A., 81, 609 Boudou, P., 81, 609 Fajardo, M.E., 559 Bousquet, J., 597 Iguchi, K., 25 Fantin, G., 63 Boyan, B.D., 363, 683 Ishizuka, S., 227, 277, 423 Farach-Carson, M.C., 357 Brown, M.A.T., 707 Ivanova, G.V., 569 Feldman, D., 293 Browne-Martin, K., 605 Iwabuchi, Y., 267 Ferraboschi, P., 803 Bula, C., 147 [washima, M., 25 Fiet, J.. 81, 609 Bury, Y., 213 Fogagnolo, M., 63 Buurman, C.J., 375 Forg6, P., 833 Jaiskeliinen, T., 223 Fountas, L., 695 Jaffuel, D., 597 Fujii, Y., 615 Calverley, M.J., 249, 539 Jan, C.-R., 505 Fujishima, T., 277 Campbell, C.H., 727 Jans, C.G.J.M., 115 Fujiwara, M., 107, 499 Campbell, M.J., 423, 433, 463 Furuta, T., 795 Javed, A., 159 Carlberg, C., 213 Jeganathan, S., 239 Celotti, F., 803 Jiang, X., 655 Chang, Y.-T., 721 Jikai, L., 771 Charalambous, A., 785 Galons, H., 81, 609 Jinming, G., 771 Ganjam, V., 845 Chen, W.-C., 505 Joe, I., 529 Gardezi, S.A., 793 Chen, Y.J., 845 Gardner, F., 59 Cheng, J.-S., 505 Ge, Z., 655 Kaastrup, P., 539 Chodounska, H., 99 Giton, F., 81, 609 Kadiyala, S., 347 Gombart, A.F., 433 Choe. S., 381 Kaltia, S.A., 777 Gomez-Sanchez, C.E., 845 Choi, M., 177 Kasal, A., 99 Gomez-Sanchez, E.P., 845 Chokki, M., 227, 277 Kashihara, M., 615 Gougat, C., 597 Chou, K.-J., 505 Kasiotis, K.M., 785 Cigliano, L., 889 Govorova, A.A., 569 Kasuya, Y., 795 Clancy, J., 663 Gradezi, S.A., 203 Kawase, A., 267 Clark, S.A., 845 Grisenti, P., 803 Khripach, V.A., 569 Colston, K.W., 309 Groen, M.B., 115, 569 Kim, H., 239 Covey, D.F., 655 Gréschl, M., 737 Klingmuller, D., 763 Guerrini, A., 63 Kneer, N., 581 PII: S0039-128X(01)00165-9 912 Author Index / Steroids 66 (2001) 911-913 Koduri, Bis Nagaba, S., 347 Sato, M., 107, 499 Koeffler, H.P., 423, 463 Nakagawa, K., 277, 327 Schneider, G., 623, 833 Kohout, L., 99 Nakakoshi, M., 743 Schnirer, I., 203, 793 Koide, S., 549 Nakamichi, Y., 25 Schiissler. M., 399, 451 Konno, K., 277 Nakamura, K., 637 Schuster, I., 399, 409, 451 Konstantinova, O.V., 569 Nakano, H., 107, 499 Schwartz, Z., 363, 683 Kostellow, A.B., 849 Nara, K., 25 Schwarz, K., 257 Kovaéevié, R., 645 Narvaez, C.J., 301 Sekeris, C.E., 695 Krieg, M., 521 Shalyapina, V.G., 883 Kriwanek, S., 287 Nguyen, C., 203, 793 Shany, S., 319 KrSiak, M., 99 Ni, C.-r., 905 Shelangouski, M., 743 Kubodera, N., 267 Nishii, Y., 137 Shen, Y.-C., 72] Kurobe, M., 277, 327 Norman, A.W., 129, 147, 227. 239, 463 Shibasaki, H., 795 Kuroki, S., 637 Numazawa, M., 743 Shimada, K., 865 Kurosawa, T., 107, 499 Shimizu, Y., 87 Shoulars, K., 707 Okai, T., 87 Sippell, W.G., 817 Lahav-Cohen, M., 319 Okamura, W.H.. Siu-Caldera, M.-L., 327, 463 Lance, V.A., 875 Okano, T., 137. Skaltsounis, A.-L., 785 Langer, G., 257 Olgiati, V., 803 Slavikova, B., 99 Lardy, H., 581 Omdahl, J.L.. 381 Smith, C., 277 Le Bail, J.-C., 749 Ordyan, N.E., 883 Smith, S.J., 59 Lee, K.-C., 505 Ortega, M.J., 897 Soliman, H., 81, 609 Leo, O., 39 Osawa, Y., 87 Solleder, C., 759 Levy; ¥.; 319 Ozono, K., 227, 327 Song, C., 473, 673 Liagre, B., 749 Song, X.-D., 147 Lian, J.B., 159 Soory, M., 857 Liao, S., 473, 673 Patton, M.L., 875 Sowa, Y., 327 Lin, H., 771 Pavao, M., | Spagnuolo, M.S., 889 Lin, S.-X., l Pedrini, P., 63 Spagnuolo, P., 423 Liu, X., 663 Peleg, S., 203, 793 Spierto, F.W., 59 Liu, Y., 845 Peng, S., 811 Stalla, G.K., 817 Liu, Penov GaSi, K.M., 645 Stankovi¢, S.M., 645 LLioun gcope, C.. 605 PPeitreiralniokv,, MG..,, 238079 SSttaerckkae,l brL.o,e c5k5, S., 763 Lu, J., 905 Pivina, S.G., 883 Stein, G.S., 159 Lu, WG., 33 Plate, R., 115 stein, J.L., 159 Luna, M.H., 683 Poirier, D., 821 Steinmeyer, A., 257 Lyakhov, A.S., 569 Polly, P., 213 Stojanovié, S.Z., 645 Pols, H.A.P., 375 Studzinski, G.P., 463 Poola, I., 17 Stuetz, A., 409 Ma, G.-Y... 849 Posner, G.H., 347 Stuetz, P., 409 MacDonald, P.N., 171 Prakash, C.V.S., 721 su, JY., 33 Mienpiiéi, P.H., 223 Pratsinis, H., 785 Swamy, N., 189 Maeyama, J., 267 Price, C.A., 511 Sylvia, V.L., 363, 683 MMaagginait,i s,A .,P .,8 0738 5 Pucciariello, R., 803 Szamel, I., 5! Szécsi. M., 833 Mahonen, A., 223 Mikela, T.H., 777 Qiu, W., 347 Maki, S.. 277 Quack, M., 213 Tachibana, Y., 9 “3 Malacara, J.M., 559 Malamitsi-Puchner, A., 695 Takayama, H., 2 // Takeuchi, A., 463 Manchand, P.S., 463 Rakitskaya, V.V., 883 Takeuchi, K., 347 Manzocchi, A., 803 Ramirez, V.D., 529 Takikawa, H., 701 Markaverich, B.M., 707 Rao, D.S.. 423, 463 Tallova, J., 55 Marwah, A., 58] Rashid, S.F., 433 Tanabe, C., 795 Marwah, P., 581 Rauh, M., 737 Tanaka, M., 637 Masuno, H., 177 Ray, R., 189 Tang, K.-Y., 505 Mathieu, M., 597 Reddy, G.S., 327, 347, 409, 423, 441, 463 Tapolcsanyi, P., 623, 833 May, B.K., 381 Reese, P.B., 481 Teranishi, M., 615 McLane, J.A., 441 RizZner, T.L., 49 Tilakaratne, A., 857 Medici, A., 63 Roan, C.-J., 505 Toell, A., 213 Medié Mijaéevié, L., 645 Rolin, S., 39 Tokumaru, H., 171 Merkel, R.A., 71 Roumestan, C., 597 Toma, Y., 87 Miura, D., 227, 277 Rouvinen, J., 223 Toth, [., 833 Mizuta, A., 637 Rueda, A., 897 Traish, A.M., 1 Mohr, S.C., 189 Ryhinen, S., 223 Tremblay, M.R., 821 Molnar Gabor, D.. 645 Tsavlovskii, D.N., 569 Montecino, M., 159 Tserng, K.-Y., 441 Morrill, G.A., 849 Saito, H., 87 Tsuji, M., 93 Mountford, J.C., 433 Saito, M., 227 Tziotis, J., 695 Moutsatsou, P., 695, 785 Sakaé, M.N., 645 Murai, T., 107, 499 Salva, J., 897 Muralidharan, K.R., 441 Sano, N., 701 Uchiyama, Y., 267 Author Index / Steroids 66 (2001) 911-913 913 Uhlifova, L., 99 Wahiala, K.T., 777 Urbain, J., 39 Wang, C., 811 Yang, J., 811 Uskokovic, M.R., 327, 347, 423, 463 Wang, J.. 65 Yoshimura, T., 107, 499 Wang, J.-L., Yudt, M.R., 549 Watson, C.S., 727 Yukihiro, S., 347 Viaisinen, S., 223 Weisser, H., 521 van den Bemd, G.-J.C.M., 375 Welsh, J., 301 van Driel, M., 375 Whetstone, R., 683 Zakelj-Mavrié, M., 49 Van Laethem, F., 39 Wiesinger, H., 257 Zavadskaya, M.I., 569 van Leeuwen, J.P.T.M., 375 Wolfling, J., 623, 833 Zeng, LM., 33 van Wijnen, A.J., 159 Wudy, S.A., 759 Zhabinskii, V.N., 569 van Wuijtswinkel, R.C.A.L.. 115 Vergne, P., 749 Zhang, C., 171 Villani, V., 803 Xie, Z., 339 Zhao, M., 811 Villette, J.-M., 81, 609 Xu, W., 189 Zhao, X.-Y., 293 Vlachos, G., 695 Zheng, J.-m., 905 Vorisek, G., 399, 409, 45] Zheng, W.-q., 905 Vu, T., 239 Yamada, S., 177 Zhu, G.-D., 239 Yamamoto, K., 177 Ziemssen, T., 521] Yanaihara, A., 87 Zinser, G., 301 Wagner, R., 737 Yanaihara, T., 87 Zubia, E., 897 Steroids ELSEVIER Steroids 66 (2001) 915-918 Subject Index of Volume 66 Acetolysis, 623 C-24 Oxidation pathway, 451, 463 Acetylenic alcohols, 569 C-3 Epimerization pathway, 441. 463 Activation function 2 domain, 203 Ca-~ signaling, 505 Adenocarcinoma, 287 Calcitroic acid, 93 Adrenai steroids, 883 Calcium, 849 Adrenal tumor, 817 Calcium channels, 347, 357 Affinity chromatography, 529 cAMP, 39 Affinity labeling, 189 Cancer, 319 Alcohols, 777 Cancer cell lines, 319 Allopregnanolone, 55, 99 Cancer cells, 433 | @,25-Dihydroxy-2B-(3-hydroxypropoxy)vitamin D,, 267 26-Carboxy-1@,24,25-trihydroxyvitamin D,, 93 la,25-dihydroxyvitamin D,, 203, 267, 287, 539 28-Carboxy-1a@,24,25-trihydroxyvitamin D,, 93 la@,25-Dihydroxyvitamin D,. 93 Catechol estrogen, 615 3a@,12a-Dihydroxy-7-0xo-5B-cholan-24-oic acid, 63 Cbfal, 159 3a.7a-Dihydroxy-12-o0xo-5B-cholan-24-oic acid, 63 Cell cycle la-Hydroxylase, 409, 451 Cell differentiation, 997 3a-Hydroxy-7,12-dioxo-5B-cholan-24-oic acid, 63 Cell maturation, 683 1a@,23(S),25(OH),-24-oxo-D,, 423 Cell proliferation, 319 1a.25(OH),-3-epi-D;, 441 Chemical synthesis, 499, 821 1 @,25(OH),-16-ene-D, analogs, 3 27 Chinese truffles, 771 la,25(OH),D,, 137, 147, 227, 339, 347, 363, 409, 423, 441 Chirality, 803 1a@,25(OH),D, (calcitriol), 293 Chlorinated steroid, 25 [email protected](OH),D, analogs, 357 Cholestenoic acid, 473 1 a.25-(OH),D,-26,23-lactone analogues, 2 Cholesterol, 473, 673 Sa-Reductase, 521 Cholesterol 7a@-hydroxylase, 637 Analgesia, 811 Cholic acid, 63 Analogs, 223, 463 Chondrocyte cultures, 683 Androgen receptor, 293 Chondrocytes, 363 Androgen receptor binding, 833 Chromatin, 159 Androgens synthesis, 645 Clavularia viridis, 25 Androstenedione, 609 ‘C-NMR spectroscopy, 249 Ansa-steroids, 239 Coactivators, 171, 213 Antagonist, 227 Competitive RT-PCR, 87 Antibody production, 539 Configurational analysis, 833 Apoptosis, 277, 301, 309, 32 Conformation, 147 A-ring conformation, 277 Conjugated reaction, 107 Aromatase, 511, 749 Conjugated steroids, 795 Ascomycetes, 771 Corepressors, 213 Atherosclerosis, 473, Corticosterone, 845, 883 4-Azasteroids, 803 Cortisol, 737, 795, 817, 883 Cortisol metabolites, 795 Cortisone, 817 Behavior, 99 Covalent |°H]luteolin binding, 707 16B-(Acetoxy )acetoxylation, 743 cPLA2, 309 16B-Acetoxylation, 743 Cushing’s disease, 817 17B-Estradiol, 529 CYP24, 409, 433, 451 118 Hydroxysteroid dehydrogenase, 49, 845 CYP27, 399 B-Oxidation, 499 Cyst fluid, 55 Bile, 93 Cytochrome P450, 391 Bile acid, 107 Cytochrome P450 aromatase, 763 Bile acid biosynthesis, 499 Cytokine, 319 Bile acid synthesis, 637 Cytotoxic activity, 785 Biliary excretion, 701 Cytotoxicity, 897 Biological activity, 803 Biotin, 609 Biotine, 81 DAST, 99 Bone, 257, 375 Daunorubicin conjugates, 785 Bone resorption, 347 D-Azasteroids, 655 Brain, 865, 883 D-bifunctional protein, 107 Branched DNA, 663 Dehydrocholic acid, 63 Breast cancer, 59, 301 1 |-Dehydrocorticosterone, 845 Breast neoplasm, 905 Dehydroepiandrosterone sulfate, 865 Pll: SO0039-128X(01)00166-0 Subject Index / Steroids 66 (2001) 915-918 Development, 883 Human keratinocytes, 409, 441 Dexamethasone, 39 Human large intestine, 287 Dibutyltin, 763 Human prostate, 521 Diels-Alder reaction, 249 Human serum, 59 Diethylstilbestrol, 505 Hybrid, 257 Differentiation, 287, 327 Hydrocortisone, 811 Dimerization, 203 Hydrolysis, 795 25-Dihydroxyvitamin D,, 277 2-hydroxyestrone, 59 1,3-Dipolar cycloaddition, 569 4-Hydroxyestrone, 615 D-Secosteroids, 645 4-Hydroxyestrone 3-methyl ether, 615 24-Hydroxylated ED-71, 267 25-Hydroxylase, 399 EB1089, 539 16-Hydroxymethyl-Sa-androstane-3B,17-diol, 623 ED-71, 137, 267 17a-Hydroxypregnenolone, 759 Eisai hyperbilirubinemic rats, 701 17-hydroxypregnenolone, 81, 759 Electrochemical anodic oxidation, 63 4-Hydroxy-6-oxoestrone, 615 17-Enol acetoxy steroid, 743 25-Hydroxyvitamin D,, 399 Enzyme, 38] 7-Hydroxy steroids, 117 Enzyme activity, 529 7B-Hydroxydehydroepiandrosterone, 58| Enzyme immunoassay, 59, 539 Hydroxysteroid dehydrogenase, 821 Enzyme-linked immunosorbent assay, 865 Hypercholesterolemia, 673 Epalon, 99 Hyperglycemia, 597 20-epi analog, 203 Hypertension, 695 20-epi-29 -methyl-la, 27777 3-Epimers, 327 Epitestosterone, 55 IGF-I, 309 ER mRNA, 905 Immunocytochemistry, 797 fal Estradiol, 71, 511. 821, 889 Immunohistochemical staining, 87 Estrogen, 59, 301, 605, 663, 749 Immunohistochemistry, 905 Estrogen receptor, 549, 905 In situ hybridization, 905 Estrogen receptor a, 1, 17, 695 Indomethacin, 857 Estrogen receptor binding, 785 Inflammatory periodontal repair, 857 Estrone, 811 Inhibition, 451 Ether and alkyl carbonate derivatives of 7-oxygenated steroids, 5 Inhibition of aromatase activity, 645 Extremophiles, 49 Inhibitors, 409, 803 Insulin, 511 Insulin resistance, 559 Fallopian tube, 87 Internal bypass, 637 Fecal metabolites, 875 Intestinal factor, 637 Fibroblasts, 857 Isihippurols A and B, 721 Follicle, 511, 889 Isis hippuris, 721 FSH, 511 Isotope-labeling, 743 Fungi, 49 Fura-2, 505 Keratinocyte differentiation, 339 Keratinocytes, 399, 451 GABA, receptor, 99, 655 KH-1060, 137 Gas chromatography, 759 Kyotorphin, 811 Gel shift clipping assay, 213 Gene expression, 597 Gene regulation, 381 Lactones, 777 GHRH, 71 L-bifunctional protein, 107 Glucocorticoids, 597, 749 Lead (IV) acetate, 743 -Glucuronidase, 795 Lignans, 777 Glucuronosides, 581 Limited protease digestion assay, 213 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 529 Linker, 811 Gonadotropins, 559 Lipid environment, 52] Gorgonian, 721, 897 Liver, 605 Granulosa, 511 Liver X receptor, 473 Granulosa cells, 889 Livial, 117 Growth hormone, 71 LXR, 673 Growth plate, 363 Mammary gland, 301 'H NMR spectroscopy, 99 Mass spectrometry, 759 Hapten, 539 MC-903, 137 Helical peptides, 549 MDCK cells, 505 HL-60 cell differentiation, 277 Membrane ER-a, 727 HL-60 cells, 227, 423 Menopause, 559 Homology modeling, 177. 189 Mesophiles, 49 Hormone-binding analysis, 189 Metabolism, 423, 441, 463, 605 HPLC analysis, 107 Metabolites, 93, 375, 463 Human, 87, 763 4-Methoxyestrone, 615 Human breast cancer cells, 309 2-Methyl-1a, 277 Subject Index / Steroids 66 (2001) 915-918 24-Methylenecholest-4-en-3 B,6B-diol, 33 -rotein dimerization, 549 16-Methyl steroids, 833 Protein kinase C, 683 Michael reactions, 777 Protein-DNA interaction, 213 Mineralocorticoid, 817 Psoriasis, 137 Molecular modeling, 249 Purification of nuclear type II [°H]estradiol binding Monobutyltin, 763 Monoclonal antibodies, | Moxestrol, 605 Quantitative plate assay, 727 mRNA quantitation, 17 Multidrug resistance protein 2, 701 Mutation, 381 24(R).25(OH),D;, 363, 683 24R-Hydroxylase, 391 Rapid actions, 363 Natural metabolites, 423 Rapid responses, 147 Neighboring group participation, 623 Rat, 319, 637, 865 Nitrile oxides, 569 Rational design, 549 NMR data, 821 Reaction mechanism, 743 19-Norsteroids, 569 Receptor, 223 Nuclear ER-a, 727 Regioselectivity, 63 Nuclear matrix, 159 Remote functionalization, 481 Nuclear receptor, 147, 171, 177 Renal tubular cells, 505 Nuclear receptor conformations, Rhinoceros, 875 Nuclear receptors, 673 Saliva, 737 Obesity, 559 Selective estrogen receptor modulator, 663 OCT; 137 Selective synthesis, 615 25-OH-D,-24-hydroxylase, 227 Serum, 865 170OH-Progesterone, 737 Side chain conformation, 249 Oocyte, 849 Signal transduction, 683 ORG OD14, 117 Soft coral, 25 Organic anions, 701 Spirofurans, 569 Osteoarthritis, 749 Splice targeted primers, 17 Osteoblasts, 35 Splice variants, 17 Osteocalcin, SRIF, 71 Osteopontin, 357 Stability, 737 Osteoporosis, | Stable isotope, 759 Osteosarcoma cells, - Steroid, 71, 99, 107, 257, 293, 381, 399, 409, 481, 499, 549, 5: Ovulatory cycle, 889 663, 673, 695, 727. 759, 763, 817, 821. 857, 889 3-O-B-D-Glucopyranosyl-(22E, 24R)-ergosta-7, 22-die, 7-Oxo-dehydroepiandrosterone, 581 Steroid hormones, 171 Steroid hydroxylases, 391 24-Oxo-5B-cholestan-26-oyl CoA, 499 Steroid inactivation, 845 Oxysterol, 473 Steroid metabolism, 391 Steroid receptors, 287 P450. 381 Steroid sulfatase, 87 p53, 905 Steroid sulfate, 473 Parathyroid hormone, 357 Steroidal non-steroidal estrogen ligand, 785 Peptidosteroid, 821 Sterol, 249, 267, 771, 897 Phosphatidylmonomethylethanolamine, 849 Structural elucidation, 25 Phospholipase C-yi, 339 Structure-function relationship, 177 Phospholipase D, 683 Suprasterols, 239 Phospholipases, 521 Synoviocytes, 749 Phospholipids, 521 Synthesis, 33, 277, 539, Phosphonate, 257 Plasma membrane, 849 Plexaurella grisea, 897 T lymphocytes, 39 p-Nitrophenol, 727 Tamoxifen, 605 Point mutation, 189 Tauroursodeoxycholate-3-sulfate, 701 Polyclonal antibodies, | Template competition RT PCR, 17 Polyhydroxylated sterol, 33 Testosterone, 71 Polyhydroxysteroids, 721 Testosterone 5a reductase, 803 Preeclampsia, 695 Tetrabutyltin, 763 Pregnancy, 695, 875 Tibolone, 117 Pregnanes, 875 Time-resolved fluoroimmunoassay, 81, 609 Pregnenolone sulfate, 55 TNFa, 309, 319 Progesterone, 529, 737, 849 trans-Activation, 597 Progesterone receptor, 663 Transcription, 159 Proliferation, 287, 433 Transcription regulation, 171 Promoter, 381 Transcriptional activity, 327 Promoter selectivity, 213 Tributyltin, 763 Prostate cancer, 293 Tuber indicum, 77} Protease, 849 Tuberoside, 771 Protein aggregation, 549 Tyrosine aminotransferase, 597 918 Subject Index / Steroids 66 (2001) 915-918 VDR, 137 Vitamin D steroid, 159 VDR binding affinity, 277 Vitamin D, 147, 177, 213, 223, 239, 257, 301, 319, 363, 375, 391, 399, 433 Wagner-Meerwein rearrangement, 623 Vitamin D analogs, 137, 249, 293, 309, 319 E Women, 749 Vitamin D receptor, 171, 203, 93, 363 Vitamin D receptor agonists, 213 Vitamin D receptor ligand-binding domain (structure), 189 Yeast, 49 Vitamin D signalling pathways, 213 Yonarasterol, 25